Literature DB >> 11427582

Practical strategies for detecting and confirming vancomycin-intermediate Staphylococcus aureus: a tertiary-care hospital laboratory's experience.

E M Marlowe1, M D Cohen, J F Hindler, K W Ward, D A Bruckner.   

Abstract

The clinical microbiology laboratory plays a critical role in the detection of Staphylococcus aureus with decreased susceptibility to vancomycin. Staff education and rapid laboratory response are of utmost importance. We report on our laboratory's experience and provide recommendations for the identification and confirmation of vancomycin-intermediate S. aureus.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11427582      PMCID： PMC88198          DOI： 10.1128/JCM.39.7.2637-2639.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

1.  Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital.

Authors:  A Marchese; G Balistreri; E Tonoli; E A Debbia; G C Schito
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Update: Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1997-09-05       Impact factor: 17.586

3.  Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.

Authors:  K Hiramatsu; N Aritaka; H Hanaki; S Kawasaki; Y Hosoda; S Hori; Y Fukuchi; I Kobayashi
Journal:  Lancet       Date:  1997-12-06       Impact factor: 79.321

4.  Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides.

Authors:  F C Tenover; M V Lancaster; B C Hill; C D Steward; S A Stocker; G A Hancock; C M O'Hara; S K McAllister; N C Clark; K Hiramatsu
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

Review 5.  Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know.

Authors:  S K Fridkin
Journal:  Clin Infect Dis       Date:  2000-12-13       Impact factor: 9.079

6.  Vancomycin-intermediate Staphylococcus aureus in Korea.

Authors:  M N Kim; C H Pai; J H Woo; J S Ryu; K Hiramatsu
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

7.  Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.

Authors:  T L Smith; M L Pearson; K R Wilcox; C Cruz; M V Lancaster; B Robinson-Dunn; F C Tenover; M J Zervos; J D Band; E White; W R Jarvis
Journal:  N Engl J Med       Date:  1999-02-18       Impact factor: 91.245

8.  Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR.

Authors:  P Vannuffel; J Gigi; H Ezzedine; B Vandercam; M Delmee; G Wauters; J L Gala
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

9.  Vancomycin-intermediate Staphylococcus aureus in a home health-care patient.

Authors:  J C Hageman; D A Pegues; C Jepson; R L Bell; M Guinan; K W Ward; M D Cohen; J A Hindler; F C Tenover; S K McAllister; M E Kellum; S K Fridkin
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883
  9 in total
  9 in total

1.  Nationwide survey shows that methicillin-resistant Staphylococcus aureus strains heterogeneously and intermediately resistant to vancomycin are not disseminated throughout Japanese hospitals.

Authors:  Y Ike; Y Arakawa; X Ma; K Tatewaki; M Nagasawa; H Tomita; K Tanimoto; S Fujimoto
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

2.  Detection of staphylococci with reduced susceptibility to glycopeptides.

Authors:  Mary Jane Ferraro; Jana M Swenson; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

Review 3.  Relationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, high vancomycin MIC, and outcome in serious S. aureus infections.

Authors:  Natasha E Holmes; Paul D R Johnson; Benjamin P Howden
Journal:  J Clin Microbiol       Date:  2012-05-16       Impact factor: 5.948

4.  Precision of vancomycin and daptomycin MICs for methicillin-resistant Staphylococcus aureus and effect of subculture and storage.

Authors:  Carmen L Charlton; Janet A Hindler; John Turnidge; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2014-08-20       Impact factor: 5.948

5.  Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period.

Authors:  Guiqing Wang; Janet F Hindler; Kevin W Ward; David A Bruckner
Journal:  J Clin Microbiol       Date:  2006-09-06       Impact factor: 5.948

6.  Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea.

Authors:  Mi-Na Kim; Sang Hyun Hwang; Yeon-Jung Pyo; Hyang-Mi Mun; Chik Hyun Pai
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

Review 7.  Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.

Authors:  Benjamin P Howden; John K Davies; Paul D R Johnson; Timothy P Stinear; M Lindsay Grayson
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

8.  Frequency of susceptibility testing for patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Carmen L Giltner; Theodoros Kelesidis; Janet A Hindler; April M Bobenchik; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2013-10-23       Impact factor: 11.677

9.  Effect of genetic background on the evolution of Vancomycin-Intermediate Staphylococcus aureus (VISA).

Authors:  Michelle Su; Michelle H Davis; Jessica Peterson; Claudia Solis-Lemus; Sarah W Satola; Timothy D Read
Journal:  PeerJ       Date:  2021-07-13       Impact factor: 3.061
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.